New jejunal CD: corticosteroids or anti-TNF
In patients with newly diagnosed jejunal CD presenting with anemia and weight loss, are systemic corticosteroids or anti-TNF preferred
What is known
- In a duodeno-jejunal crohn's series, all patients received steroids for the first attack and 75% required immunosuppression for steroid dependence. 1
- Case reports of proximal/gastric crohn's describe steroid dependence and osteoporosis prompting transition to infliximab maintenance. 2,3
- In a pediatric IBD cohort, anemia and corticosteroid use at biologic initiation were markers of more severe disease and predicted biologic discontinuation. 4
What is unknown / caveats
- No head-to-head steroid vs anti-TNF induction trial for jejunal/proximal crohn's in the retrieved corpus
- Evidence is case reports and small/pediatric cohorts, not surgical-corpus comparative data
- The corpus is crohn's-surgery focused and does not contain the medical induction-therapy trials needed to answer this directly.
References
- Andant C, Godeberge B, Chaussade S, Dupas JL, Soulé JC. [Clinical course of symptomatic duodeno-jejunal Crohn's disease]. Gastroenterol Clin Biol. 1999. PMID: 10651532.
- Ibrahim SH, Smyrk TC, Faubion WA. Treatment of isolated gastric Crohn's disease with inhaled corticosteroids. Case Rep Gastroenterol. 2008. PMID: 21490870.
- Racz JM, Davies W. Severe stricturing Crohn's disease of the duodenum: A case report and review of surgical options. Int J Surg Case Rep. 2012;3(7):242-5. PMID: 22503915.
- Kaplan JL, Liu C, King EC, Bass JA, Patel AS, Tung J, Chen S, Lissoos T, Candela N, Saeed S, Colletti RB, for the ImproveCareNow N. Use, Durability, and Risks for Discontinuation of Initial and Subsequent Biologics in a Large Pediatric-Onset IBD Cohort. J Pediatr Gastroenterol Nutr. 2023. PMID: 36804501.
For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.
Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.
Sources retrieved: PMID 34932900 · PMID 25796553 · PMID 36804501 · PMID 38034441 · PMID 21490870 · PMID 28372453 · PMID 22503915 · PMID 10651532 · PMID 24310524 · PMID 23894777
answered 2026-08-04 · corpus build b71369a6 · faithfulness 0.8888888888888888
Reviewer notes